Did You Know?

Editor’s Picks

Latest News

Rhelion Life Sciences Confirms Further Delivery of Filament Health’s PEX010 to Germany’s First Psilocybin Compassionate Use Program

Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting...

Action Behavior Centers’ Family Advocacy Team Meets with U.S. Senators in North Carolina to Discuss Access to ABA Therapy for Autism

A visit to ABC's Clayton ABA therapy center connected legislative staff with the realities families face when accessing ABA therapy...

error: Content is protected !!